Technology Industry
Industry: Email Alert RSS FeedParadigm Genetics Inc
BT Catalyst, Dec, 2001
* Paradigm Genetics Inc. (Nasdaq: PDGM) of Research Triangle Park has received its first U.S. Patent. Patent 6,303,365, titled "Method of determining activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5-phosphate synthase," is for a gene that produces a potential herbicide target protein.
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
It was discovered jointly by Paradigm and Bayer AG of Leverkusan, Germany, through a commercial partnership.
COPYRIGHT 2001 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning